A functional polymorphism in the CYP3A4 gene is associated with increased risk of coronary heart disease in the Chinese Han population.

作者: Bao-xia He , Lei Shi , Jian Qiu , Liang Tao , Rui Li

DOI: 10.1111/J.1742-7843.2010.00657.X

关键词: Reporter geneBiologyCYP3A4GastroenterologyOdds ratioInternal medicineCoronary heart diseaseGenotypeGeneticsGeneCytochrome P450Allele

摘要: Abstract:  CYP3A4 is a major member of the cytochrome P450 (CYP) enzymes which play crucial roles in cardiovascular diseases. Recently, novel polymorphism gene, IVS10 + 12G>A, named CYP3A4*1G (rs2242480), has been identified. The aim this study was to evaluate potential relationship between allele and susceptibility coronary heart disease (CHD). A total 628 individuals (322 unrelated patients with CHD 306 age- sex-matched healthy controls) were investigated study. Polymerase chain reaction–restriction fragment length (PCR-RFLP) used identify CYP3A4*1G. We also analysed functional significance IVS10 + 12G>A using dual-luciferase reporter assay. results showed that frequency 0.290 CYP3A4*1G/*1G genotype 0.090 CHD. had higher risk, an odds ratio (OR) 3.84 (p = 0.025; 95% CI = 1.32–12.65) after adjustment for conventional risk factors. gender-dependent difference observed. significantly female than controls (p = 0.034, OR = 3.02, CI = 1.04–8.70). Furthermore, assay indicated at transcriptional activity G allele. Our imply contributes Chinese Han population, may be useful specific molecular pathogenesis

参考文章(43)
Vural Ozdemir, Werner Kalow, Bing-Kou Tang, Andrew Paterson, Scott Walker, Laszlo Endrenyi, Angela Kashuba, Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics. ,vol. 10, pp. 373- 388 ,(2000) , 10.1097/00008571-200007000-00001
Ramachandran S. Vasan, Johan Ärnlöv, Michael J. Pencina, Shreyasee Amin, Byung-Ho Nam, Emelia J. Benjamin, Joanne M. Murabito, Thomas J. Wang, Philip E. Knapp, Ralph B. D'Agostino, Shalendar Bhasin, Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men Annals of Internal Medicine. ,vol. 145, pp. 176- 184 ,(2006) , 10.7326/0003-4819-145-3-200608010-00005
Joyce A. Goldstein, Diana Dai, Ernest Hodgson, Randy Rose, Jun Tang, Rachelle J. Bienstock, Harvey W. Mohrenweiser, Identification of Variants of CYP3A4 and Characterization of Their Abilities to Metabolize Testosterone and Chlorpyrifos Journal of Pharmacology and Experimental Therapeutics. ,vol. 299, pp. 825- 831 ,(2001)
Yuan Gao, Li-rong Zhang, Qiang Fu, CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin. European Journal of Clinical Pharmacology. ,vol. 64, pp. 877- 882 ,(2008) , 10.1007/S00228-008-0502-X
J K Williams, M R Adams, H S Klopfenstein, Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. ,vol. 81, pp. 1680- 1687 ,(1990) , 10.1161/01.CIR.81.5.1680
Jatinder K. Lamba, Yvonne S. Lin, Kenneth Thummel, Ann Daly, Paul B. Watkins, Stephen Strom, Jiong Zhang, Erin G. Schuetz, Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics. ,vol. 12, pp. 121- 132 ,(2002) , 10.1097/00008571-200203000-00006
R. McPherson, A. Pertsemlidis, N. Kavaslar, A. Stewart, R. Roberts, D. R. Cox, D. A. Hinds, L. A. Pennacchio, A. Tybjaerg-Hansen, A. R. Folsom, E. Boerwinkle, H. H. Hobbs, J. C. Cohen, Common allele on chromosome 9 associated with coronary heart disease Science. ,vol. 316, pp. 1488- 1491 ,(2007) , 10.1126/SCIENCE.1142447
Anthony J. Lee, May Xiaoxin Cai, Paul E. Thomas, Allan H. Conney, Bao Ting Zhu, Characterization of the Oxidative Metabolites of 17β-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms Endocrinology. ,vol. 144, pp. 3382- 3398 ,(2003) , 10.1210/EN.2003-0192
Genovefa D. Kolovou, Katherine K. Anagnostopoulou, Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Research Reviews. ,vol. 6, pp. 94- 108 ,(2007) , 10.1016/J.ARR.2006.11.001
Marcia F. Kalin, Barnett Zumoff, Sex hormones and coronary disease: a review of the clinical studies. Steroids. ,vol. 55, pp. 330- 352 ,(1990) , 10.1016/0039-128X(90)90058-J